GO:0016560 protein import into peroxisome matrix, docking: Docking Complex, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0016560 describes the docking step in which a peroxisome targeting sequence (PTS) receptor bound to a PTS-bearing protein engages the peroxisomal membrane translocation machinery.
• The docking step is part of the larger peroxisomal matrix protein import pathway, which is essential for peroxisome biogenesis and function.
• Key proteins involved include PEX5, PEX7, PEX13, PEX14, and PEX17, which form the docking complex at the peroxisomal membrane.
• Docking is a regulated, dynamic process that ensures cargo-loaded receptors are properly positioned for subsequent translocation and recycling.
• Defects in docking components are linked to peroxisome biogenesis disorders (PBDs), including Zellweger spectrum disorders, with severe neurological and metabolic consequences.
• Studying GO:0016560 requires combining genetic, biochemical, and imaging approaches, with CRISPR-based models offering precise tools to dissect docking factor function.
Description
Peroxisomes are single-membrane organelles that carry out essential metabolic functions, including fatty acid oxidation, ether lipid synthesis, and detoxification of reactive oxygen species. The import of matrix proteins into peroxisomes is a unique process because fully folded, even oligomeric, proteins are translocated across the peroxisomal membrane. This import pathway relies on cytosolic receptors that recognize peroxisome targeting sequences (PTS1 or PTS2) on cargo proteins and deliver them to the peroxisomal membrane. GO:0016560, protein import into peroxisome matrix, docking, captures the specific step where the cargo-loaded receptor docks with the membrane-embedded translocation machinery. This step is a critical checkpoint that ensures fidelity and efficiency of peroxisomal matrix protein import. The docking process is mediated by a conserved set of peroxins (PEX proteins) that form the docking complex, including PEX13, PEX14, and in some organisms PEX17. The receptor PEX5, which recognizes PTS1 cargo, and PEX7, which recognizes PTS2 cargo, must physically interact with this complex to initiate translocation. Dysfunction in docking leads to peroxisome biogenesis disorders, underscoring its biomedical importance. Understanding the molecular details of docking is therefore essential for researchers studying organelle biogenesis, protein trafficking, and related diseases. Recent studies have revealed that docking is not a static event but involves dynamic conformational changes and regulatory modifications, including ubiquitination of the receptor. These findings have opened new avenues for investigating how docking is controlled and how its dysregulation contributes to disease. This article provides a comprehensive overview of GO:0016560, covering its definition, mechanism, key genes, disease relevance, and research methodologies, with a focus on CRISPR-based approaches for functional dissection.
protein import into peroxisome matrix, docking At A Glance
| GO ID | GO:0016560 |
|---|---|
| GO term | protein import into peroxisome matrix, docking |
| Ontology | biological_process |
| Synonym | peroxisome matrix protein import, docking; peroxisome receptor docking; protein docking during peroxisome matrix protein import; protein docking during protein import into peroxisome matrix; protein docking during protein transport into peroxisome matrix; protein transport into peroxisome matrix, docking |
| Major function | Docking of PTS receptor-cargo complexes with the peroxisomal membrane translocation machinery |
| Cellular location | Peroxisomal membrane |
| Key components | PEX5, PEX7, PEX13, PEX14, PEX17 |
| Related process | Peroxisomal matrix protein import; peroxisome biogenesis |
| Disease association | Peroxisome biogenesis disorders (e.g., Zellweger spectrum disorders) |
What Is GO:0016560?
GO:0016560, protein import into peroxisome matrix, docking, is defined as the process in which a complex formed of a peroxisome targeting sequence (PTS) receptor bound to a PTS-bearing protein docks with translocation machinery in the peroxisomal membrane. In simpler terms, it is the step where the cargo-carrying receptor physically engages the protein import machinery on the peroxisome surface, preparing the cargo for translocation into the organelle matrix.
Why Is protein import into peroxisome matrix, docking Important in Cell Biology?
GO:0016560 is a critical step in peroxisomal matrix protein import, a process essential for peroxisome function and cellular metabolism. Without proper docking, cargo proteins cannot be translocated into the peroxisome matrix, leading to defective peroxisomes and severe metabolic imbalances. This step is highly conserved across eukaryotes, from yeast to humans, highlighting its fundamental importance. Mutations in docking components cause peroxisome biogenesis disorders, which present with devastating neurological, hepatic, and skeletal abnormalities. Moreover, recent insights into the dynamic regulation of docking, including receptor ubiquitination, have linked this step to broader cellular signaling pathways. Thus, understanding docking mechanisms is vital for both basic cell biology and translational research.
• Docking is the first committed step of peroxisomal matrix protein import, ensuring that only correctly loaded receptors engage the translocation machinery.
• It is essential for peroxisome biogenesis and function, impacting fatty acid oxidation, plasmalogen synthesis, and ROS detoxification.
• Defects in docking proteins cause peroxisome biogenesis disorders, including Zellweger spectrum disorders, with severe clinical outcomes.
• Docking is a conserved process across eukaryotes, making it a valuable model for studying organelle protein import.
• The step is dynamically regulated by ubiquitination and recycling of receptors, linking it to cellular stress responses.
• Research on docking provides insights into how cells maintain organelle homeostasis and respond to metabolic demands.
• Docking components are potential therapeutic targets for diseases caused by peroxisomal dysfunction.
• Studying docking with CRISPR models enables precise dissection of gene function and disease mechanisms.
What Happens During protein import into peroxisome matrix, docking?
Recognition and Loading of Cargo onto PTS Receptors
In simple terms: First, the receptor grabs the cargo protein in the cytosol.
In the cytosol, the PTS1 receptor PEX5 recognizes proteins bearing a C-terminal PTS1 tripeptide, while the PTS2 receptor PEX7 binds to proteins with an N-terminal PTS2 nonapeptide. This recognition is highly specific and ensures that only appropriate cargo is targeted to peroxisomes. The receptor-cargo complex is then directed to the peroxisomal membrane. This step is a prerequisite for docking and is tightly regulated to prevent premature cargo release.
Engagement of the Receptor-Cargo Complex with the Docking Complex
In simple terms: The receptor with its cargo then physically docks onto the peroxisome membrane.
The cargo-loaded receptor docks with the peroxisomal membrane translocation machinery, a complex that includes PEX13, PEX14, and in some organisms PEX17. PEX14 is a key component that interacts directly with PEX5, facilitating the docking event. This interaction is thought to induce conformational changes that prepare the receptor for translocation. The docking complex is embedded in the peroxisomal membrane and serves as the entry point for matrix proteins.
Conformational Changes and Receptor Modifications During Docking
In simple terms: Docking triggers changes in the receptor that help move the cargo inside.
Upon docking, the receptor undergoes conformational changes and is subject to post-translational modifications, particularly ubiquitination. Ubiquitination of PEX5 at a conserved cysteine residue is a key regulatory event that can lead to receptor recycling or degradation. These modifications are essential for the progression of import and for maintaining the pool of available receptors. The docking step is thus not merely a static binding event but a dynamic regulatory node.
Translocation Initiation and Receptor Recycling
In simple terms: After docking, the cargo is moved into the peroxisome and the receptor is recycled.
Following docking, the cargo protein is translocated into the peroxisomal matrix, while the receptor is recycled back to the cytosol for further rounds of import. The translocation step is coupled to docking and involves additional peroxins such as PEX10, PEX12, and PEX2, which form the RING finger complex. Receptor recycling is dependent on ubiquitination and the action of AAA-ATPases PEX1 and PEX6. Defects in any of these steps can impair peroxisomal matrix protein import and lead to disease.
Key Genes Involved in GO:0016560 protein import into peroxisome matrix, docking
The following genes encode proteins that are directly involved in or regulate the docking step of peroxisomal matrix protein import (GO:0016560).
| Gene | Major Role | Research Relevance |
|---|---|---|
| PEX5 | PTS1 receptor that binds cargo and docks with PEX14 | Central to docking; mutations cause PBDs; target for functional studies |
| PEX7 | PTS2 receptor that binds cargo and interacts with docking complex | Involved in PTS2-dependent import; defects cause rhizomelic chondrodysplasia punctata |
| PEX13 | Docking complex component; interacts with PEX5 | Essential for docking; mutations linked to PBDs |
| PEX14 | Docking complex component; primary binding partner of PEX5 | Key docking factor; studied for its role in receptor recognition |
| PEX17 | Accessory docking factor in some organisms | Modulates docking efficiency; less understood in humans |
| PEX10 | RING finger peroxin involved in translocation after docking | Mutations cause PBDs; functions downstream of docking |
| PEX12 | RING finger peroxin; part of translocation machinery | Required for import; interacts with docking complex |
| PEX2 | RING finger peroxin; ubiquitin ligase for receptor | Regulates receptor ubiquitination during docking/import |
| PEX1 | AAA-ATPase for receptor recycling | Mutations cause PBDs; acts after docking |
| PEX6 | AAA-ATPase for receptor recycling | Cooperates with PEX1; defects lead to PBDs |
| PEX26 | Membrane anchor for PEX1/PEX6 | Facilitates receptor recycling; mutations cause PBDs |
| PEX3 | Peroxisomal membrane protein; involved in peroxisome assembly | Indirectly affects docking by forming peroxisomes |
| PEX16 | Peroxisomal membrane protein; peroxisome biogenesis | Required for membrane formation; impacts docking |
| PEX19 | Chaperone for peroxisomal membrane proteins | Delivers docking complex components to membrane |
| UBB | Ubiquitin precursor; modifies PEX5 during docking | Regulates receptor recycling and degradation |
| USP9X | Deubiquitinase that may regulate PEX5 stability | Potential modulator of docking efficiency |
How Is protein import into peroxisome matrix, docking Regulated?
The docking step of peroxisomal matrix protein import is regulated at multiple levels. Post-translational modification of PEX5 by ubiquitination is a key regulatory mechanism that controls receptor recycling and degradation. This ubiquitination is mediated by the RING finger peroxins PEX2, PEX10, and PEX12, which act as E3 ligases. Additionally, the AAA-ATPases PEX1 and PEX6, along with their membrane anchor PEX26, are required for extracting ubiquitinated PEX5 from the membrane, a process coupled to docking and translocation. Cellular metabolic status and oxidative stress can influence peroxisomal import, although the exact signaling pathways remain to be fully elucidated. The availability of PTS receptors and the composition of the docking complex are also subject to regulation, ensuring that import capacity matches cellular needs.
protein import into peroxisome matrix, docking and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PEX5 | Zellweger spectrum disorder; PTS1 import defect | Knockout or point-mutation cell lines; patient fibroblasts |
| PEX7 | Rhizomelic chondrodysplasia punctata type 1; PTS2 import defect | Knockout mice; CRISPR-edited cells |
| PEX13 | Zellweger spectrum disorder; docking complex defect | Knockout cell models; overexpression of mutant |
| PEX14 | Zellweger spectrum disorder; docking defect | Knockout and knock-in models; imaging studies |
| PEX1 | Zellweger spectrum disorder; receptor recycling defect | Patient-derived cells; CRISPR correction |
Peroxisome Biogenesis Disorders (PBDs)
Mutations in genes encoding docking complex components or related peroxins cause peroxisome biogenesis disorders, a group of autosomal recessive diseases that include Zellweger spectrum disorders. These disorders are characterized by defective peroxisomal matrix protein import, leading to impaired fatty acid oxidation, plasmalogen deficiency, and accumulation of very long-chain fatty acids. Clinical features include severe neurological dysfunction, hypotonia, seizures, liver disease, and skeletal abnormalities. The severity correlates with the specific gene affected and the residual activity of the import pathway.
Neurological Manifestations
Docking defects particularly affect the nervous system, as peroxisomes are crucial for neuronal development and function. Zellweger spectrum disorders present with profound neurological impairment, including developmental delay, hearing loss, and vision problems. The underlying mechanisms involve disrupted lipid metabolism and oxidative stress in neurons. Research using cellular and animal models has linked docking dysfunction to neurodegeneration, highlighting the importance of this step for brain health.
Cancer and Metabolic Reprogramming
Emerging evidence suggests that peroxisomal function, including matrix protein import, is altered in certain cancers. Cancer cells often exhibit metabolic reprogramming that may involve changes in peroxisomal activity. While direct mutations in docking genes are rare in cancer, dysregulation of peroxisomal pathways can contribute to tumorigenesis and drug resistance. Further research is needed to fully understand the role of docking in cancer biology.
From protein import into peroxisome matrix, docking-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of PEX5 abolish docking? | PEX5 knockout cell line (CRISPR-Cas9) |
| How does a specific PEX14 mutation affect docking? | Point-mutation knock-in of PEX14 |
| Can tagged PEX13 be used to visualize docking? | Knock-in of fluorescent tag (e.g., GFP) at PEX13 locus |
| Does overexpression of PEX7 enhance PTS2 import? | PEX7 overexpression cell line |
| What is the interactome of the docking complex? | Affinity purification with tagged PEX14 followed by mass spectrometry |
| Can CRISPR screening identify novel docking regulators? | Genome-wide CRISPR knockout library screening |
How to Study the protein import into peroxisome matrix, docking Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Fluorescence microscopy | Co-localization and dynamics of docking factors | Visualizing docking in live cells |
| Co-immunoprecipitation | Protein-protein interactions | Mapping docking complex interactions |
| Mass spectrometry | Protein composition and modifications | Identifying novel docking regulators |
| CRISPR-Cas9 knockout | Gene function loss | Testing requirement of genes in docking |
| CRISPR knock-in | Tagged protein expression | Imaging and biochemical studies |
| RNA interference | Gene knockdown | Transient suppression of docking genes |
| Yeast two-hybrid | Binary protein interactions | Screening for docking partners |
| In vitro import assays | Protein translocation into peroxisomes | Measuring docking and import efficiency |
Fluorescence Microscopy and Live-Cell Imaging
Fluorescence microscopy is widely used to study peroxisomal docking by visualizing the co-localization of PTS receptors with peroxisomal membrane markers. Tagged versions of PEX5, PEX13, or PEX14 can be expressed in cells to monitor their dynamic interactions in real time. Advanced techniques such as FRET and super-resolution microscopy can reveal conformational changes during docking. These methods are essential for understanding the spatiotemporal regulation of docking.
Biochemical Assays for Protein Interactions
Co-immunoprecipitation, pull-down assays, and crosslinking studies are used to detect and quantify interactions between PTS receptors and docking complex components. These assays can be performed with purified proteins or cell lysates to map binding domains and identify critical residues. For example, the interaction between PEX5 and PEX14 has been extensively characterized using such methods. Biochemical assays also allow assessment of the effects of disease-causing mutations on docking.
Proteomics and Mass Spectrometry
Mass spectrometry-based proteomics can identify proteins that co-purify with docking complex components, revealing the composition and dynamics of the import machinery. Quantitative proteomics can also measure changes in peroxisomal matrix protein import efficiency upon genetic perturbation. These approaches have been used to define the importomer and its associated factors. Proteomics is particularly powerful when combined with CRISPR-based knockout or knock-in models.
CRISPR-Cas9 Genome Editing
CRISPR-Cas9 technology enables precise genetic manipulation of docking genes to study their function. Knockout cell lines can be generated to assess the requirement for specific peroxins in docking. Point mutations can be introduced to model disease-associated variants and dissect domain functions. Knock-in of tags or reporters allows visualization and biochemical isolation of docking complexes. These models are invaluable for linking genotype to phenotype in peroxisomal import.
How CRISPR Can Be Used to Study GO:0016560 protein import into peroxisome matrix, docking
Knockout
CRISPR-Cas9 knockout of docking genes such as PEX5, PEX13, or PEX14 results in loss of peroxisomal matrix protein import and provides a clean background to study docking defects. These knockout cell lines can be used to assess the requirement for specific domains and to test compensatory mechanisms. They also serve as models for peroxisome biogenesis disorders.
Point Mutation
Introducing disease-associated point mutations into docking genes using CRISPR-Cas9 allows researchers to study the molecular basis of impaired docking. For example, mutations in PEX5 that affect PEX14 binding can be modeled to understand their impact on import. Point-mutation knock-in cell lines are valuable for testing targeted therapies.
Knock-in
Knock-in of fluorescent tags (e.g., GFP, mCherry) or epitope tags at endogenous loci enables real-time visualization and biochemical isolation of docking complexes. Tagged PEX13 or PEX14 can be used to track their localization and interactions during docking. This approach preserves endogenous regulation and stoichiometry.
Overexpression
Overexpression of docking components or their mutants can reveal dominant-negative effects or enhance import capacity. For instance, overexpressing PEX5 may increase PTS1 import, while overexpressing a binding-deficient mutant may impair docking. Overexpression models are useful for structure-function studies and for identifying rate-limiting steps.
How EDITGENE Supports protein import into peroxisome matrix, docking Research
Researchers studying protein import into peroxisome matrix, docking-related genes often need to determine whether a candidate gene is causally involved in docking, how specific mutations affect function, and what the downstream consequences are for peroxisomal import and cellular physiology. EDITGENE provides a comprehensive suite of CRISPR-based services to address these questions with precision and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for protein import into peroxisome matrix, docking research.
Frequently Asked Questions About protein import into peroxisome matrix, docking
What is GO:0016560?
GO:0016560 is the Gene Ontology term for protein import into peroxisome matrix, docking, the step where a PTS receptor-cargo complex docks with the peroxisomal membrane translocation machinery.
What genes are involved in protein import into peroxisome matrix, docking?
Key genes include PEX5, PEX7, PEX13, PEX14, and PEX17, which encode components of the docking complex and receptors.
What happens during peroxisomal matrix protein docking?
The cargo-loaded PTS receptor binds to docking complex proteins on the peroxisomal membrane, triggering conformational changes and preparing for translocation.
Why is docking important for peroxisome function?
Docking is essential for importing matrix proteins, which are required for fatty acid oxidation, plasmalogen synthesis, and ROS detoxification.
What diseases are linked to defects in peroxisomal docking?
Mutations in docking genes cause peroxisome biogenesis disorders, including Zellweger spectrum disorders, with severe neurological and metabolic symptoms.
How is docking regulated?
Docking is regulated by ubiquitination of PEX5 and recycling via PEX1/PEX6 ATPases, ensuring dynamic control of import.
What methods are used to study peroxisomal docking?
Common methods include fluorescence microscopy, co-immunoprecipitation, mass spectrometry, and CRISPR-Cas9 genome editing.
Can CRISPR be used to study docking genes?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect docking gene function.
What is the role of PEX5 in docking?
PEX5 is the PTS1 receptor that binds cargo and docks with PEX14 on the peroxisomal membrane.
How does EDITGENE support docking research?
EDITGENE provides CRISPR cell models, library screening, and bioinformatics services to study docking genes and their role in disease.
Conclusion
GO:0016560, protein import into peroxisome matrix, docking, represents a critical and dynamic step in peroxisomal biology. It ensures that PTS-bearing cargo proteins are correctly delivered to the peroxisomal membrane for translocation, a process essential for organelle function and cellular metabolism. Dysregulation of docking leads to severe peroxisome biogenesis disorders, highlighting its biomedical significance. Advances in CRISPR-based models and imaging technologies continue to unravel the molecular details of docking, offering new opportunities for therapeutic intervention. Researchers can leverage EDITGENE's services to generate precise genetic models and accelerate discoveries in this field.
References
- 1. Eckert JH et al.. 2003. Peroxisome biogenesis.. Rev Physiol Biochem Pharmacol 147:75-121 PMID: 12687401
- 2. Waterham HR et al.. 1997. Peroxisome biogenesis.. Bioessays 19(1):57-66 PMID: 9008417
- 3. Skowyra ML et al.. 2022. PEX5 translocation into and out of peroxisomes drives matrix protein import.. Mol Cell 82(17):3209-3225.e7 PMID: 35931083
- 4. Fujiki Y et al.. 2014. Peroxisome biogenesis in mammalian cells.. Front Physiol 5:307 PMID: 25177298
- 5. Verplaetse E et al.. 2012. Studies on the organization of the docking complex involved in matrix protein import into glycosomes of Trypanosoma brucei.. Biochem Biophys Res Commun 424(4):781-5 PMID: 22809509
- 6. Rayapuram N et al.. 2006. The importomer--a peroxisomal membrane complex involved in protein translocation into the peroxisome matrix.. Biochim Biophys Acta 1763(12):1613-9 PMID: 17027097
- 7. Wolf J et al.. 2010. Peroxisomes as dynamic organelles: peroxisomal matrix protein import.. FEBS J 277(16):3268-78 PMID: 20629744
- 8. Francisco T et al.. 2014. Ubiquitin in the peroxisomal protein import pathway.. Biochimie 98:29-35 PMID: 23954799
